Good morning :)
Place Order
Add to Watchlist

Nath Bio-Genes (I) Ltd

NATHBIOGEN Share Price

207.201.94% (+3.94)
High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP

With a market cap of ₹386 cr, stock is ranked 2,004

Stock is 2.81x as volatile as Nifty

How to use scorecard? Learn more

With a market cap of ₹386 cr, stock is ranked 2,004

Stock is 2.81x as volatile as Nifty

NATHBIOGEN Performance & Key Metrics

NATHBIOGEN Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
10.010.630.98%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
36.559.221.70%

NATHBIOGEN Analyst Ratings & Forecast

Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

NATHBIOGEN Company Profile

Nath Bio-Genes (India) is engaged in hybrid seed business and production, processing and marketing of hybrid and genetically modified (GM) seeds

NATHBIOGEN Similar Stocks (Peers)

Compare with peers Compare with peers 

NATHBIOGEN Similar Stocks (Peers)

Compare with peers Compare with peers 
PE Ratio
34.65
34.65
1Y Return
27.68%
27.68%
Buy Reco %
83.33
83.33
PE Ratio
21.33
21.33
1Y Return
18.55%
18.55%
Buy Reco %
100.00
100.00
PE Ratio
29.01
29.01
1Y Return
9.45%
9.45%
Buy Reco %
0.00
0.00
BNHOLDINGS
PE Ratio
92.90
92.90
1Y Return
24.31%
24.31%
Buy Reco %
0.00
0.00
PE Ratio
37.65
37.65
1Y Return
21.73%
21.73%
Buy Reco %
0.00
0.00
Compare with Peers

NATHBIOGEN Sentiment Analysis

NATHBIOGEN Sentiment Analysis

New
Crisp summary & key insights to decode earnings calls instantly

NATHBIOGEN Stock Summary · May 2025

In FY '25, the company showcased resilience through significant growth in its non-cotton and non-paddy segments, particularly in bajra, maize, and vegetable seeds, while also expanding internationally into markets like the Philippines and Uzbekistan. Despite modest EBITDA growth due to necessary investments, management remains optimistic, targeting INR 500 crores in sales and a long-term goal of INR 1,000 crores. Enhanced infrastructure and operational readiness position the company well for the upcoming market season, even as challenges in the cotton market persist. A strategic focus on research and development, alongside improved working capital management, underscores a commitment to innovation and competitive differentiation, paving the way for sustained growth amidst evolving market dynamics.

NATHBIOGEN Stock Growth Drivers
NATHBIOGEN Stock Growth Drivers
6
  • Strong Financial Performance

    Nath Bio-Genes has reported solid growth in its non-cotton, non-paddy portfolio, which has become a

  • Product Innovation and Diversification

    The company has expanded its product portfolio with the introduction of new biotonic products aimed

NATHBIOGEN Stock Challenges
NATHBIOGEN Stock Challenges
5
  • Decline in Paddy Volumes

    The company has reported a minor year-over-year decline in paddy volumes, with figures showing a

  • Decreased Recoveries from Provisions

    There has been a significant decrease in recoveries from provisions made in previous years, dropping

NATHBIOGEN Forecast

NATHBIOGEN Forecasts

empty forecast

Forecast data is currently unavailable

Forecast data is currently unavailable

Price

Price Upside

Revenue

Revenue Growth

Earnings

Earnings Per Share

NATHBIOGEN

NATHBIOGEN

Income

Balance Sheet

Cash Flow

NATHBIOGEN Income Statement

NATHBIOGEN Income Statement

Loading...

Financial YearFY 2022FY 2023FY 2024FY 2025TTM
Total Revenue280.21301.91336.70369.99370.00
Raw Materialssubtract3.565.3112.26315.11315.11
Power & Fuel Costsubtract1.071.391.13
Employee Costsubtract24.7823.3227.58
Selling & Administrative Expensessubtract89.99112.25139.47
Operating & Other expensessubtract210.53110.26102.23
Depreciation/Amortizationsubtract3.083.013.263.823.83
Interest & Other Itemssubtract10.6410.219.2010.4810.49
Taxes & Other Itemssubtract3.951.131.951.981.99
EPS-35.4618.4320.8520.1420.30
DPS2.002.002.002.002.00
Payout ratio0.110.100.100.10

NATHBIOGEN Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2024FY 2024

Annual report

PDF

Investor Presentation

Aug 10PDF
FY 2023FY 2023

Annual report

PDF

Investor Presentation

Apr 22PDF
Feb 14PDF
Oct 20PDF
Aug 13PDF
FY 2022FY 2022

Annual report

PDF

Investor Presentation

May 30PDF
Feb 14PDF
Nov 1PDF
Aug 10PDF
FY 2021FY 2021

Annual report

PDF

Investor Presentation

Jun 24PDF
FY 2020FY 2020

Annual report

PDF
FY 2019FY 2019

Annual report

PDF
FY 2018FY 2018

Annual report

PDF
FY 2017FY 2017

Annual report

PDF
FY 2016FY 2016

Annual report

PDF
FY 2015FY 2015

Annual report

PDF
 

NATHBIOGEN Stock Peers

NATHBIOGEN Past Performance & Peer Comparison

NATHBIOGEN Past Performance & Peer Comparison

Comparing 3 stocks from 
Consumer StaplesAgro Products

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Nath Bio-Genes (I) Ltd10.010.630.98%
Godrej Agrovet Ltd34.655.101.42%
Gujarat Ambuja Exports Ltd21.331.920.22%
Jubilant Agri and Consumer Products Ltd29.0111.07

NATHBIOGEN Stock Price Comparison

Compare NATHBIOGEN with any stock or ETF
Compare NATHBIOGEN with any stock or ETF
NATHBIOGEN
Loading...

NATHBIOGEN Holdings

NATHBIOGEN Shareholdings

NATHBIOGEN Promoter Holdings Trend

NATHBIOGEN Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

NATHBIOGEN Institutional Holdings Trend

NATHBIOGEN Institutional Holdings Trend

Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

NATHBIOGEN Shareholding Pattern

NATHBIOGEN Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding45.60%3.89%0.05%0.21%50.25%

Jun 2024

Sep 2024

Dec 2024

Mar 2025

NATHBIOGEN Shareholding History

NATHBIOGEN Shareholding History

Dec '23MarJunSepDec '24Mar0.32%0.27%0.22%0.19%0.19%0.21%

Mutual Funds Invested in NATHBIOGEN

Mutual Funds Invested in NATHBIOGEN

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

Top 1 Mutual Funds holding Nath Bio-Genes (I) Ltd


Funds (Top 1)Market-cap heldWeight3M holding changePortfolio rank
(3M change)
2.3262%0.15%-0.08%39/88 (-2)

Compare 3-month MF holding change on Screener

NATHBIOGEN Insider Trades & Bulk Stock Deals

NATHBIOGEN Insider Trades & Bulk Stock Deals

Loading...

smallcases containing NATHBIOGEN stock

smallcases containing NATHBIOGEN stock

Looks like this stock is not in any smallcase yet.

NATHBIOGEN Events

NATHBIOGEN Events

NATHBIOGEN Dividend Trend

No dividend trend available

Dividends

Corp. Actions

Announcements

Legal Orders

NATHBIOGEN Dividend Trend

No dividend trend available

NATHBIOGEN Upcoming Dividends

NATHBIOGEN Upcoming Dividends

No upcoming dividends are available

NATHBIOGEN Past Dividends

NATHBIOGEN Past Dividends

Cash Dividend

Ex DateEx DateAug 9, 2024

Final
Final | Div/Share: ₹2.00

Dividend/Share

2.00

Ex DateEx Date

Aug 9, 2024

Cash Dividend

Ex DateEx DateJul 4, 2023

Final
Final | Div/Share: ₹2.00

Dividend/Share

2.00

Ex DateEx Date

Jul 4, 2023

Cash Dividend

Ex DateEx DateJun 23, 2022

Final
Final | Div/Share: ₹2.00

Dividend/Share

2.00

Ex DateEx Date

Jun 23, 2022

Cash Dividend

Ex DateEx DateAug 18, 2021

Final
Final | Div/Share: ₹2.00

Dividend/Share

2.00

Ex DateEx Date

Aug 18, 2021

NATHBIOGEN Stock News & Opinions

NATHBIOGEN Stock News & Opinions

Corporate
Nath Bio-Genes (India) to convene AGM

Nath Bio-Genes (India) announced that the 32th Annual General Meeting(AGM) of the company will be held on 22 August 2025.Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Board of Nath Bio-Genes (India) recommends final dividend

Nath Bio-Genes (India) announced that the Board of Directors of the Company at its meeting held on 29 April 2025, inter alia, have recommended the final dividend of Rs 2 per equity Share (i.e. 20%) , subject to the approval of the shareholders.Powered by Capital Market - Live

1 month agoCapital Market - Live
Earnings
Nath Bio-Genes (India) consolidated net profit declines 43.51% in the March 2025 quarter

Net profit of Nath Bio-Genes (India) declined 43.51% to Rs 1.48 crore in the quarter ended March 2025 as against Rs 2.62 crore during the previous quarter ended March 2024. Sales rose 20.75% to Rs 51.97 crore in the quarter ended March 2025 as against Rs 43.04 crore during the previous quarter ended March 2024. For the full year,net profit declined 2.57% to Rs 38.60 crore in the year ended March 2025 as against Rs 39.62 crore during the previous year ended March 2024. Sales rose 9.71% to Rs 364.91 crore in the year ended March 2025 as against Rs 332.62 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales51.9743.04 21 364.91332.62 10 OPM %0.819.13 -13.6414.99 - PBDT2.913.27 -11 43.8641.38 6 PBT1.572.28 -31 40.0438.11 5 NP1.482.62 -44 38.6039.62 -3 Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Nath Bio-Genes (India) to table results

Nath Bio-Genes (India) will hold a meeting of the Board of Directors of the Company on 29 April 2025.Powered by Capital Market - Live

1 month agoCapital Market - Live
Earnings
Nath Bio-Genes (India) consolidated net profit declines 30.81% in the December 2024 quarter

Net profit of Nath Bio-Genes (India) declined 30.81% to Rs 2.65 crore in the quarter ended December 2024 as against Rs 3.83 crore during the previous quarter ended December 2023. Sales rose 16.16% to Rs 36.87 crore in the quarter ended December 2024 as against Rs 31.74 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales36.8731.74 16 OPM %21.7817.77 - PBDT4.622.85 62 PBT3.792.09 81 NP2.653.83 -31 Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Nath Bio-Genes (India) to convene board meeting

Nath Bio-Genes (India) will hold a meeting of the Board of Directors of the Company on 23 January 2025.Powered by Capital Market - Live

5 months agoCapital Market - Live
Earnings
Nath Bio-Genes (India) consolidated net profit declines 26.49% in the September 2024 quarter

Net profit of Nath Bio-Genes (India) declined 26.49% to Rs 1.11 crore in the quarter ended September 2024 as against Rs 1.51 crore during the previous quarter ended September 2023. Sales rose 42.62% to Rs 32.19 crore in the quarter ended September 2024 as against Rs 22.57 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales32.1922.57 43 OPM %14.9422.06 - PBDT1.912.61 -27 PBT1.091.85 -41 NP1.111.51 -26 Powered by Capital Market - Live

7 months agoCapital Market - Live
Earnings
Nath Bio-Genes (India) standalone net profit rises 79.50% in the September 2024 quarter

Net profit of Nath Bio-Genes (India) rose 79.50% to Rs 2.89 crore in the quarter ended September 2024 as against Rs 1.61 crore during the previous quarter ended September 2023. Sales rose 42.62% to Rs 32.19 crore in the quarter ended September 2024 as against Rs 22.57 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales32.1922.57 43 OPM %20.3822.60 - PBDT3.692.72 36 PBT2.861.96 46 NP2.891.61 80 Powered by Capital Market - Live

7 months agoCapital Market - Live
Corporate
Nath Bio-Genes (India) announces board meeting date

Nath Bio-Genes (India) will hold a meeting of the Board of Directors of the Company on 23 October 2024.Powered by Capital Market - Live

8 months agoCapital Market - Live
Earnings
Nath Bio-Genes (India) consolidated net profit declines 0.24% in the June 2024 quarter

Net profit of Nath Bio-Genes (India) declined 0.24% to Rs 33.35 crore in the quarter ended June 2024 as against Rs 33.43 crore during the previous quarter ended June 2023. Sales rose 3.66% to Rs 243.88 crore in the quarter ended June 2024 as against Rs 235.28 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales243.88235.28 4 OPM %14.9815.74 - PBDT34.4334.38 0 PBT33.6033.62 0 NP33.3533.43 0 Powered by Capital Market - Live

10 months agoCapital Market - Live

Frequently asked questions

Frequently asked questions

  1. What is the share price of Nath Bio-Genes (I) Ltd (NATHBIOGEN) today?

    The share price of NATHBIOGEN as on 17th June 2025 is ₹207.20. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on Nath Bio-Genes (I) Ltd (NATHBIOGEN) share?

    The past returns of Nath Bio-Genes (I) Ltd (NATHBIOGEN) share are
    • Past 1 week: 5.61%
    • Past 1 month: 9.00%
    • Past 3 months: 42.46%
    • Past 6 months: 5.45%
    • Past 1 year: 4.05%
    • Past 3 years: 26.88%
    • Past 5 years: -39.44%

  3. What are the peers or stocks similar to Nath Bio-Genes (I) Ltd (NATHBIOGEN)?
  4. What is the dividend yield % of Nath Bio-Genes (I) Ltd (NATHBIOGEN) share?

    The current dividend yield of Nath Bio-Genes (I) Ltd (NATHBIOGEN) is 0.98.

  5. What is the market cap of Nath Bio-Genes (I) Ltd (NATHBIOGEN) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Nath Bio-Genes (I) Ltd (NATHBIOGEN) is ₹386.28 Cr as of 17th June 2025.

  6. What is the 52 week high and low of Nath Bio-Genes (I) Ltd (NATHBIOGEN) share?

    The 52-week high of Nath Bio-Genes (I) Ltd (NATHBIOGEN) is ₹264.31 and the 52-week low is ₹137.55.

  7. What is the PE and PB ratio of Nath Bio-Genes (I) Ltd (NATHBIOGEN) stock?

    The P/E (price-to-earnings) ratio of Nath Bio-Genes (I) Ltd (NATHBIOGEN) is 10.01. The P/B (price-to-book) ratio is 0.63.

  8. Which sector does Nath Bio-Genes (I) Ltd (NATHBIOGEN) belong to?

    Nath Bio-Genes (I) Ltd (NATHBIOGEN) belongs to the Consumer Staples sector & Agro Products sub-sector.

  9. How to buy Nath Bio-Genes (I) Ltd (NATHBIOGEN) shares?

    You can directly buy Nath Bio-Genes (I) Ltd (NATHBIOGEN) shares on Tickertape. Simply sign up, connect your demat account and place your order.